Homart Pharmaceuticals, a Sydney vitamins and beauty products business, is eyeing an ASX float next year as revenues approach $130 million and investors look for opportunities in the sector following the departure of industry giant Blackmores after a $1.9 billion buyout.
Homart manufactures and sells vitamins and supplements brands SpringLeaf, Top Life, Urvita and Health’N’Nature, and owns the Cheri anti-ageing beauty products brand.
Loading...
Simon Evans writes on business specialising in retail, manufacturing, beverages, mining and M&A. He is based in Adelaide. Connect with Simon on Twitter. Email Simon at simon.evans@afr.com
